{"name": "RareCyte",
 "permalink": "rarecyte",
 "crunchbase_url": "http://www.crunchbase.com/company/rarecyte",
 "homepage_url": "http://www.rarecyte.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@rarecyte.com",
 "phone_number": "206-455-9092",
 "description": "",
 "created_at": "Thu Aug 23 03:23:11 UTC 2012",
 "updated_at": "Thu Aug 23 03:29:25 UTC 2012",
 "overview": "\u003Cp\u003ERareCyte is a life science research and diagnostic development company focused on characterizing and isolating rare cells in the blood. RareCyte is dedicated to bringing its innovative technology to the Life Sciences research, drug development, and diagnostic markets providing new tools to answer difficult questions related to cancer and cardiovascular disease. RareCyte\u0026#8217;s ground-breaking AccuCyte system is an open platform for the unbiased discovery and isolation of circulating tumor cells (CTCs) and circulating endothelial cells (CECs) from whole blood. \u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       52],
      "assets/images/resized/0020/7605/207605v1-max-150x150.jpg"],
     [[235,
       83],
      "assets/images/resized/0020/7605/207605v1-max-250x250.jpg"],
     [[235,
       83],
      "assets/images/resized/0020/7605/207605v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [{"round_code": "unattributed",
    "source_url": "http://in.finance.yahoo.com/news/rarecyte-completes-final-tranche-funding-162000178.html",
    "source_description": "RareCyte Completes Final Tranche of Funding for Launch of its AccuCyte Rare Cell Detection Platform",
    "raised_amount": null,
    "raised_currency_code": null,
    "funded_year": 2012,
    "funded_month": 8,
    "funded_day": 21,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Telegraph Hill Partners",
         "permalink": "telegraph-hill",
         "image":
          {"available_sizes":
            [[[111,
               74],
              "assets/images/resized/0004/8656/48656v1-max-150x150.jpg"],
             [[111,
               74],
              "assets/images/resized/0004/8656/48656v1-max-250x250.jpg"],
             [[111,
               74],
              "assets/images/resized/0004/8656/48656v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "228 9th Avenue North",
    "address2": "Suite 100",
    "zip_code": "98109",
    "city": "Seattle",
    "state_code": "WA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        108],
       "assets/images/resized/0020/7606/207606v1-max-150x150.jpg"],
      [[250,
        181],
       "assets/images/resized/0020/7606/207606v1-max-250x250.jpg"],
      [[450,
        326],
       "assets/images/resized/0020/7606/207606v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}